Development of a Predictive Nomogram for Intraoperative Massive Transfusion in Patients with Placenta Accreta Spectrum: A Retrospective Cohort Study

Why It Matters

Accurate prediction of massive transfusion risk enables obstetric teams to allocate blood products proactively, reducing hemorrhage‑related complications and optimizing resource use in high‑risk deliveries.

Key Takeaways

• 36.7% of PAS patients required massive intraoperative transfusion
• Gestational bleeding, low pre‑op hemoglobin, and PAS type predict transfusion need
• Nomogram AUC reached 0.76, indicating good discrimination
• Model specificity 84% and NPV 78% at 40.5% cut‑off
• Tool supports personalized blood‑bank planning for obstetric teams

Pulse Analysis

Placenta accreta spectrum disorders represent a growing obstetric challenge, accounting for a disproportionate share of postpartum hemorrhage and maternal morbidity. As cesarean deliveries become more common, the incidence of PAS rises, intensifying the demand for precise blood‑product management. Clinicians have long relied on generic transfusion protocols, but these often fail to capture patient‑specific risk factors, leading to either over‑stocking or critical shortages during surgery. A predictive framework that integrates clinical cues can transform how hospitals prepare for these high‑stakes deliveries.

In the recent study, researchers examined 87 PAS cases over an 11‑year span, applying LASSO variable selection and multivariate logistic regression to isolate three independent predictors: active gestational bleeding, lower pre‑operative hemoglobin, and more invasive PAS subtypes (increta or percreta). These variables fed into a nomogram that yielded an area under the ROC curve of 0.763, a respectable discrimination metric for a relatively small cohort. At the optimal 40.5% probability cut‑off, the model delivered 83.6% specificity and a negative predictive value of 78%, suggesting it can reliably rule out massive transfusion needs in the majority of cases.

The practical implications are significant. By flagging patients with a high predicted probability of massive transfusion, anesthesiologists, obstetricians, and blood‑bank managers can mobilize additional units, coordinate cross‑matching, and activate rapid‑response protocols before the incision. This targeted approach not only curtails unnecessary blood product waste but also enhances patient safety by ensuring timely availability of life‑saving resources. As health systems increasingly adopt data‑driven decision tools, the PAS nomogram could serve as a template for similar predictive models across other high‑risk surgical domains, fostering more efficient and personalized peri‑operative care.